The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia
2013 ◽
Vol 39
(4)
◽
pp. 264-269
2014 ◽
pp. 113-128
2010 ◽
Vol 107
(12)
◽
pp. 1943-1947
◽
2002 ◽
Vol 19
(6)
◽
pp. 426-435
◽